Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer
NCT01980849
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
272
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
Nadroparin, long term
DRUG:
Nadroparin: short-term
Sponsor
Shengqing Li